Rapid Micro Biosystems, Inc. (RPID)
Automate Your Wheel Strategy on RPID
With Tiblio's Option Bot, you can configure your own wheel strategy including RPID - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol RPID
- Rev/Share 0.6739
- Book/Share 1.4887
- PB 2.2302
- Debt/Equity 0.0897
- CurrentRatio 4.6134
- ROIC -0.6604
- MktCap 145521244.0
- FreeCF/Share -0.8818
- PFCF -3.7513
- PE -3.258
- Debt/Assets 0.0688
- DivYield 0
- ROE -0.5607
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | RPID | KeyBanc Capital Markets | -- | Overweight | -- | $8 | Feb. 12, 2025 |
News
Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript
Published: May 09, 2025 by: Seeking Alpha
Sentiment: Neutral
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Mike Beaulieu - VP, IR and Corporate Communications Rob Spignesi - President and CEO Sean Wirtjes - CFO Conference Call Participants Dan Arias - Stifel Paul Knight - KeyBanc Capital Markets Chad Wiatrowski - TD Cowen Operator Thank you for standing by. My name is RG, and I will be your conference operator today.
Read More
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Negative
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.31 per share a year ago.
Read More
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
Published: May 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
LEXINGTON, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2025.
Read More
Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript
Published: February 28, 2025 by: Seeking Alpha
Sentiment: Neutral
Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q4 2024 Earnings Conference Call February 28, 2025 8:00 AM ET Company Participants Mike Beaulieu – Vice President, Investor Relations and Corporate Communications Rob Spignesi – President and Chief Executive Officer Sean Wirtjes – Chief Financial Officer Conference Call Participants Dan Arias – Stifel Paul Knight – KeyBanc Brendan Smith – TD Cowen Operator Thank you for standing by. My name is Eloisa, and I will be your conference operator today.
Read More
Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates
Published: February 28, 2025 by: Zacks Investment Research
Sentiment: Negative
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.26 per share a year ago.
Read More
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
Published: February 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the fourth quarter and full year ended December 31, 2024.
Read More
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025
Published: February 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
LEXINGTON, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2024 financial results prior to the market open on Friday, February 28, 2025.
Read More
About Rapid Micro Biosystems, Inc. (RPID)
- IPO Date 2021-07-15
- Website https://www.rapidmicrobio.com
- Industry Medical - Devices
- CEO Mr. Robert G. Spignesi Jr.
- Employees 163